Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06828289

Rivastigmine Mini-Tablet for Alzheimer's Disease

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the efficacy and safety of rivastigmine mini-tablets in individuals diagnosed with mild to moderate Alzheimer's disease (AD).

Official title: Observational Study of Rivastigmine Mini-Tablet in Patients with Alzheimer's Disease

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2025-02-28

Completion Date

2026-12-31

Last Updated

2025-02-20

Healthy Volunteers

No

Interventions

DRUG

Rivastigmine Mini-Tablet

Treatment group: Rivastigmine Mini-Tablet

DRUG

Donepezil Hydrochloride

Control group: Donepezil Hydrochloride